Home > Boards > US Listed > Biotechs >

Inovio Biomedical Corp. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator subslover, OceanEagle1, pistol1p, kablahm, biovalidator
Search This Board:
Last Post: 7/30/2014 9:21:26 PM - Followers: 397 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
Wiki
INO News: Securities Registration Statement (simplified Form) (s-3) 07/23/2014 04:33:27 PM
INO News: Current Report Filing (8-k) 07/23/2014 01:07:25 PM
INO News: Current Report Filing (8-k) 07/23/2014 09:21:19 AM
INO News: Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 07/23/2014 09:15:00 AM
INO News: Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes 07/01/2014 04:00:00 AM
PostSubject
#11886  Sticky Note INOVIO RESPONDS - FRESH OFF THE PRESS - CCruzNY 06/11/14 09:10:07 AM
#11802  Sticky Note New ino Article http://m.seekingalpha.com/article/2259253-too-many-pending-mile Fsa888 06/09/14 12:54:48 PM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#12340   I agree that nothing negative has happened on pistol1p 07/30/14 09:21:26 PM
#12339   Everywhereman...Where are you? We need your assessment Peterconway13 07/30/14 09:02:44 PM
#12337   This action in the opposite of what I Quanic Buds 07/30/14 07:54:55 PM
#12336   Another stunning day for INO (I don't think!) ppnlf 07/30/14 04:33:10 PM
#12335   Hope he saved his profits for the lawyers celtic 07/30/14 02:51:34 PM
#12334   This has gone viral! KingDMC 07/30/14 02:38:06 PM
#12333   Thanks for sharing Limp biscuit 07/30/14 11:16:38 AM
#12332   Immunotherapies and Vaccine Summit (August 11 -14) DrBob99 07/30/14 10:56:52 AM
#12331   CREW Requests SEC Investigate Manipulation of Drug Company CHM_760 07/30/14 09:21:19 AM
#12330   Over the last two years we have seen pistol1p 07/29/14 11:10:12 PM
#12329   We do deserve better, but I suspect that Autumnforest 07/29/14 03:43:12 PM
#12328   INO got more than handful avg 11.33 spades 07/29/14 03:40:51 PM
#12327   It's really sad when I feel happy at ppnlf 07/29/14 03:04:01 PM
#12326   The market will only buy validation as evidenced ppnlf 07/29/14 01:49:16 PM
#12325   I guess the validation of the entire pipeline tomlewis727 07/29/14 01:20:52 PM
#12324   Are we expecting news soon? Limp biscuit 07/29/14 12:57:17 PM
#12323   Manipulation Tate 07/29/14 12:05:37 PM
#12322   Wth is going on with this stock the Limp biscuit 07/29/14 12:01:09 PM
#12321   Without news this is unfortunately heading one direction ppnlf 07/29/14 11:09:27 AM
#12320   Shorts bringing this down today- hold your shares! Tate 07/29/14 10:17:25 AM
#12319   * * $INO Video Chart 7-28-14 * * ClayTrader 07/29/14 08:42:22 AM
#12318   Thanks! I look forward to hearing your full Peterconway13 07/28/14 10:47:06 PM
#12317   Here it is E-Man celtic 07/28/14 09:18:48 PM
#12316   I agree with you. cameron12x 07/28/14 06:20:20 PM
#12315   Skating to where the puck is going to be? Yooper61 07/28/14 06:04:59 PM
#12314   The reason for the initial disappointment was that cameron12x 07/28/14 05:43:19 PM
#12313   * * $INO Video Chart 7-28-14 * * ClayTrader 07/28/14 05:37:03 PM
#12312   I cannot remember either. But now its a Everywhereman 07/28/14 04:32:43 PM
#12311   Mostly the scientists were very impressed. I personally Everywhereman 07/28/14 04:31:42 PM
#12310   I feel assured I have time to jump cracity 07/28/14 02:36:18 PM
#12309   That would be nice. The share price performance ppnlf 07/28/14 02:29:18 PM
#12308   Details of PH2 due early Aug. nypete 07/28/14 02:18:53 PM
#12307   I'm out for now. Not gonna watch mt cracity 07/28/14 10:51:26 AM
#12306   I think you are correct. Partnership news could cracity 07/28/14 10:26:59 AM
#12305   E-Man, Great times in INO land!!!!! as usual celtic 07/28/14 09:40:18 AM
#12304   It's ALL going to be about combination therapies cameron12x 07/26/14 03:04:01 PM
#12303   This is where we all get to experience future1 07/26/14 01:02:51 PM
#12302   I am not eman but 100% chance that Spareinvestor 07/26/14 10:36:09 AM
#12301   I will also be curious to hear more ImaPseudonym 07/26/14 09:42:18 AM
#12300   Hi Everywherman! I was hoping you could Peterconway13 07/26/14 12:56:04 AM
#12299   What is the earliest I will be able nanopatent 07/25/14 03:21:29 PM
#12298   I hole you are correct. I only need cracity 07/25/14 01:28:12 PM
#12297   I don't think they want it there. They future1 07/25/14 11:50:57 AM
#12296   VGX-3100 results not a home run but still MrDanMan 07/25/14 10:48:46 AM
#12295   Let's hope price goes up. Considering the great cracity 07/25/14 09:36:24 AM
#12294   26% of mkt capital not 7%. This is cwwan1 07/24/14 07:34:58 PM
#12293   Even Motley Fool is on board Rule_62 07/24/14 04:11:28 PM
#12292   Stock split opinion. future1 07/24/14 12:06:13 PM
#12291   http://www.theflyonthewall.com/permalinks/entry.php/INOid2043339/INO-Inovio cracity 07/24/14 11:54:21 AM
#12290   Aegis Capital raises price target to $19 (from CHM_760 07/24/14 11:21:58 AM
PostSubject